← Back to Events

Clinical Management of Patients with a Positive National Bowel Cancer Screening Test

Topic:
Clinical Management of Patients with a Positive National Bowel Cancer Screening Test in the Tasmanian context
Speaker:
Dr Hooi Ee, Gastroenterologist, Sir Charles Gairdner Hospital Perth; a working party member and contributor to Clinical practice guidelines for the prevention, early detection and management of colorectal cancer.
Date & Time:
7.00pm - 8.30pm Wednesday 19 May, 2021
Location:
Online webinar
Audience:
General practitioners, nurse practitioners, practice nurses, gastroenterologists, general surgeons, registrars, and endoscopy staff

Primary Health Tasmania, with the support of The Tasmanian Bowel Cancer Prevention Program – Tasmania Health Service, have facilitated this webinar. It is designed to update health professionals on the National Health and Medical Research Council endorsed clinical management of patients with a positive National Bowel Cancer Screening Test in the Tasmanian context.

Dr Hooi Ee will present on:

  • bowel cancer and risk factors
  • the principles of population-based screening and the case for a bowel screening program
  • the current status of the National Bowel Cancer Screening Program
  • clinical management: key principles and case scenarios.

Dr Ee will be joined by local specialists and primary healthcare professionals for a live, interactive panel discussion and Q&A session.

 

Dr Ee is a full-time clinical gastroenterologist, training supervisor and Head of the Department of Gastroenterology, Sir Charles Gairdner Hospital in Perth. He is the Clinical Advisor to the WA Department of Health on bowel cancer screening and is a co-author of the NHMRC-approved guidelines on colorectal cancer screening, screening based on family history and colonoscopic surveillance. He is also the bowel screening Expert  Advisor to the National Cancer Screening Registry and has been invited to membership of the Clinical Advisory Group of the National Bowel Cancer Screening Program.